The Coordination Committee of the Technological Platform for Innovative Medicines defines its action plan for 2025 Madrid will host the 18th Annual Conference of Biomedical Research […]

Our country is the leader in Europe with 930 clinical studies authorised in 2024. 22% of research to find new drugs is aimed at rare diseases […]

The Aemps authorised a total of 930 studies last year, making it the European regulatory agency that approved the most clinical trials, ahead of countries such […]

The International Federation of Innovative Pharmaceutical Industry publishes the Facts & Figures 2024 report, which outlines the industry’s contribution globally. In 2023, the industry filed 12,425 […]

Pipeline Innovation Review, carried out by the consultancy firm Iqvia for the European Federation of the Pharmaceutical Industry (Efpia) and Vaccines Europe, covers biomedical research underway […]

Farmaindustria and Levante-EMV hold a meeting with experts to discuss the creation of the ‘ICAP Guide’ of good practices for the promotion of clinical research in […]

The trial, which will evaluate a vaccine under clinical investigation by GSK, will be conducted in Phase I units at La Paz, La Princesa and Puerta […]

The percentage of GDP that the state spends on pharmaceuticals has not increased in the last 20 years. Between 2018 and 2023, the increase in the […]

The head of Innovation and director of Innovation at Farmaindustria, Miguel González, highlighted how Artificial Intelligence (AI) has brought about a paradigm shift and a revolution […]

A report by PwC for the European Federation of the Pharmaceutical Industry shows that the pharmaceutical industry contributes an economic value to the EU of 311,000 […]

Farmaindustria presents ‘The pharmaceutical industry and its context in Spain 2024’, the first report that brings together in a single volume all the figures of the […]

One year after the presentation of the ‘Guide of good practice recommendations for the promotion of clinical research in primary care’, promoted by Farmaindustria, successful initiatives […]